Genomic DNA-chip hybridization reveals a higher incidence of genomic amplifications in pancreatic cancer than conventional comparative genomic hybridization and leads to the identification of novel candidate genes

Cancer Research

Volumn 64, Issue 13, 2004, Pages 4428-4433

  Holzmann, Karlheinz ^a,d   Kohlhammer, Holger ^a   Schwaenen, Carsten ^a   Wessendorf, Swen ^a   Kestler, Hans A ^a   Schwoerer, Alexandra ^a   Rau, Bettina ^b   Radlwimmer, Bernd ^c   Döhner, Hartmut ^a   Lichter, Peter ^c   Gress, Thomas ^a   Bentz, Martin ^a  

^a UNIVERSITY OF ULM   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d Chip Facility   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 3; GENOMIC DNA; PROTEIN BCL 10; PROTEIN BCL 6; TRANSCRIPTION FACTOR NFAT;

ARTICLE; CANCER CELL CULTURE; CHROMOSOME 20Q; CHROMOSOME ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA HYBRIDIZATION; DNA MICROARRAY; GENE AMPLIFICATION; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; ONCOGENE MYC; PANCREAS CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 20; CONSENSUS SEQUENCE; CYCLIN D1; FEMALE; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LIVER NEOPLASMS; MALE; MAP KINASE KINASE KINASES; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; POLYMERASE CHAIN REACTION; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; TRANS-ACTIVATORS;

EID: 3042743983     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0431     Document Type: Article

References (44)

1. Schwab M. Oncogene amplification in solid tumors. Semin Cancer Biol 1999;9: 319-25.
2. King CR, Kraus MH, Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science (Wash DC) 1985;229:974-6.
3. Solinas-Toldo S, Wallrapp C, Muller-Pillasch F, et al. Mapping of chromosomal imbalances in pancreatic carcinoma by comparative genomic hybridization. Cancer Res 1996;56:3803-7.
4. Mahlamaki EH, Hoglund M, Gorunova L, et al. Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes Cancer 1997;20:383-91.
5. Curtis LJ, Li Y, Gerbault-Seureau M, et al. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 1998;53:42-55.
6. Schleger C, Arens N, Zentgraf H, Bleyl U, Verbeke C. Identification of frequent chromosomal aberrations in ductal adenocarcinoma of the pancreas by comparative genomic hybridization (CGH). J Pathol 2000;191:27-32.
7. Mahlamaki EH, Barlund M, Tanner M, et al. Frequent amplification of 8q24, 11q, 17q, and 20q-specific genes in pancreatic cancer. Genes Chromosomes Cancer 2002;35:353-8.
8. Joos S, Scherthan H, Speicher MR, et al. Detection of amplified DNA sequences by reverse chromosome painting using genomic tumor DNA as probe. Hum Genet 1993;90:584-9.
9. Wessendorf S, Schwänen C, Kohlhammer H, et al. Hidden gene amplifications in aggressive B-cell non-Hodgkin's lymphomas detected by microarray-based comparative genomic hybridization. Oncogene 2003;22:1425-9.
10. Solinas-Toldo S, Lampel S, Stilgenbauer S, et al. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997;20:399-407.
11. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998; 20:207-11.
12. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999;23:41-6.
13. Vila MR, Lloreta J, Schussler MH, et al. New pancreas cancer cell lines that represent distinct stages of ductal differentiation. Lab Investig 1995;72:395-404.
14. Elsasser HP, Lehr U, Agricola B, Kern HF. Establishment and characterisation of two cell lines with different grade of differentiation derived from one primary human pancreatic adenocarcinoma. Virchows Arch B Cell Pathol Incl Mol Pathol 1992;61: 295-306.
15. Iwamura T, Caffrey TC, Kitamura N, et al. P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Res 1997;57:1206-12.
16. Wessendorf S, Fritz B, Wrobel G, et al. Automated screening for genomic imbalances using matrix-based comparative genomic hybridization. Lab Investig 2002;82:47-60.
17. Wallrapp C, Hahnel S, Boeck W, et al. Loss of the Y chromosome is a frequent chromosomal imbalance in pancreatic cancer and allows differentiation to chronic pancreatitis. Int J Cancer 2001;91:340-4.
18. Baudis M, Bentz M. Comparative genomic hybridization for the analysis of leukemias and lymphomas. In: Faguet GB, editor. Hematological malignancies, methods and techniques. Totowa, NJ: Humana Press; 2001. p. 43-64.
19. du-Manoir S, Schrock E, Bentz M, et al. Quantitative analysis of comparative genomic hybridization. Cytometry 1995;19:27-41.
20. Lichter P, Bentz M, Joos S. Detection of chromosomal aberrations by means of molecular cytogenetics: painting of chromosomes and chromosomal subregions and comparative genomic hybridization. Methods Enzymol 1995;254:334-59.
21. Gress TM, Muller-Pillasch F, Geng M, et al. Pancreatic cancer-specific expression profile. Oncogene 1996;13:1819-30.
22. Knuutila S, Bjorkqvist AM, Autio K, et al. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am J Pathol 1998;152:1107-23.
23. Casalone R, Meriggi F, Forni E, Pasquali F. Cytogenetic findings in a case of anaplastic carcinoma of the pancreas. Cancer Genet Cytogenet 1987;29:253-9.
24. Johansson B, Bardi G, Heim S, et al. Nonrandom chromosomal rearrangements in pancreatic carcinomas. Cancer (Phila) 1992;69:1674-81.
25. Griffin CA, Hruban RH, Long PP, et al. Chromosome abnormalities in pancreatic adenocarcinoma. Genes Chromosomes Cancer 1994;9:93-100.
26. Lucas PC, Yonezumi M, Inohara N, et al. Bcl10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-KB signaling pathway. J Biol Chem 2001;276:19012-9.
27. Ye H, Dogan A, Karran L, et al. BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma. Am J Pathol 2000;157:1147-54.
28. Albagli-Curiel O. Ambivalent role of BCL6 in cell survival and transformation. Oncogene 2003;22:507-16.
29. Shvarts A, Brummelkamp TR, Scheeren F, et al. A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling. Genes Dev 2002;16:681-6.
30. Kurosu T, Fukuda T, Miki T, Miura O. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene 2003;22:4459-68.
31. Bos R, van-Diest PJ, van-der-Groep P, et al. Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1alpha (HIF-1alpha). Oncogene 2003;22:8948-51.
32. Ing YL, Leung IW, Heng HH, Tsui LC, Lassam NJ. MLK-3: identification of a widely-expressed protein kinase bearing an SH3 domain and a leucine zipper-basic region domain. Oncogene 1994;9:1745-50.
33. Gansauge S, Gansauge F, Ramadani M, et al. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 1997;57:1634-7.
34. Ghadimi BM, Schrock E, Walker RL, et al. Specific chromosomal aberrations and amplification of the AIB1 nuclear receptor coactivator gene in pancreatic carcinomas. Am J Pathol 1999;154:525-36.
35. Collins C, Rommens JM, Kowbel D, et al. Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma. Proc Natl Acad Sci USA 1998;95:8703-8.
36. Collins C, Volik S, Kowbel D, et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001;11:1034-42.
37. Watanabe T, Imoto I, Katahira T, et al. Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers. Jpn J Cancer Res 2002;93: 1114-22.
38. Bar-Shira A, Pinthus JH, Rozovsky U, et al. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res 2002;62:6803-7.
39. Nonet GH, Stampfer MR, Chin K, et al. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 2001;61: 1250-5.
40. Leach RE, Duniec-Dmuchowski ZM, Pesole G, et al. Identification, molecular characterization, and tissue expression of OVCOV1. Mamm Genome 2002;13: 619-24.
41. Bossolasco M, Lebel M, Lemieux N, Mes-Masson AM. The human TDE gene homologue: localization to 20q13.1-13.3 and variable expression in human tumor cell lines and tissue. Mol Carcinog 1999;26:189-200.
42. Besco JA, Frostholm A, Popesco MC, Burghes AH, Rotter A. Genomic organization and alternative splicing of the human and mouse RPTPrho genes. BMC Genomics 2001;2:1.
43. Luo C, Burgeon E, Carew JA, et al. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol 1996;16:3955-66.
44. Jauliac S, Lopez-Rodriguez C, Shaw LM, et al. The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 2002;4:540-4.